46 Biggest Movers From Yesterday
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday.
34 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday.
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios’ Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
HC Wainwright & Co. Maintains Buy on AcelRx Pharmaceuticals, Lowers Price Target to $5
HC Wainwright & Co. analyst Ed Arce maintains AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy and lowers the price target from $7 to $5.
AcelRx Pharmaceuticals: Q2 Earnings Insights
Shares of AcelRx Pharmaceuticals (NASDAQ:ACRX) fell 6.8% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were flat 0.00% over the past year to ($0.08), which were in line with the estimate of ($0.08).